The CellMaker airlift single use bioreactor system provides a fast  solution for microbial fermentation. With a compact size, our  self-contained bioreactor has a lower footprint than others on the  market. Our system has been proven with bacteria, yeast and microalgae.

The airlift system enables excellent mixing and aeration  suitable for both oxygen hungry and anaerobic bacterial processes. Not only is the CellMaker very effective in growing bacteria, it also  reduces downtime and cleaning required.  

Bacteriophage can be used to treat bacterial infections and are useful  in fields such as medicine, veterinary science, and agriculture. 

Fighting and destroying bacterial infections in humans and animals  are the primary applications of phage therapy. After antibiotics were  discovered, phage therapy research declined in the western world.  However, with the current rise in threat of antimicrobial resistance,  phages provide a promising solution.

Clients using the CellMaker in their own laboratory have already seen  bacteriophage amplified to unprecedented levels in comparison to  traditional methods.

Mammalian cell culture requires controlled levels of various gasses  coupled with continuous gentle movement. We believe the CellMaker Plus  is perfectly suited for this application, and we are currently testing  numerous mammalian processes using our system. 

Contact us to discuss  your mammalian processes further. 

The patented airlift technology eliminates the need for mechanical  mixing, instead using bubbles to move cells and nutrients, providing  optimal aeration for rapid growth of cells.
This method of gentle agitation is suitable for microbial fermentation  and cell culture. For optimal control, we offer dissolved oxygen and pH  regulation, alongside accurate temperature control. The integrated  heater cooler allows temperatures from 16°C to 40°C without the need for  external equipment. 

"We have found the CellMaker reliable, easy to use  and invaluable in our Pharmaceutical processes. Our qualified team likes  working with this bioreactor, using the advantages of disposable  technologies. The CellMaker produces the quantity and quality of bacteriophage that we are looking for. The 4 CellMaker systems have  become a vital part of a production process of our innovative BAFASAL®  product."
- Dr. Arkadiusz Wojtasik, Project Director, Proteon Pharmaceuticals S.A.

We are recruiting Key Opinion Leaders in the US with expertise in bacteriophage research for partnership opportunities... This is a win-win collaboration to advance the science in the fight against antibiotic-resistant bacteria! 

Complete the form below to find-out more...